Interferon Therapy as an Emerging Strategy for Treatment of Covid-19: An Overview

Corona virus disease (COVID-19) is an infectious disease and a type of deadly respiratory pandemic caused by the SARS-nCoV-2 virus. Most of the people who fall sick with this COVID-19 pandemic will experience mild to moderate symptoms. This virus transmits mainly between people who are in close contacts and causes outbreaks that can be controlled by implementing targeted measures. Interferons are proteins that are released by the cells in response to detection of pathogens either outside or inside the cell. They belong to the family of cytokines with antiviral properties. So, these interferons have been suggested as a potential therapy for COVID-19.Interferon beta-1a, and interferon alfa-2b are both under investigation as potential treatments for people who are infected with COVID-19.Interferon beta has become the focus of intensifying efforts in Britain, china, and the US to treat covid-19 pandemic. Administering the interferon to patients could invigorate their defenses in the early stages of illness. In addition, people those who are exposed to smoking and having heart related disorders should be more aware because they are more vulnerable to covid-19